{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:58:24Z","timestamp":1781643504333,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Human Immunodeficiency Virus (HIV) reported alarmingly increase daily, and poses threat to epidemic control globally. A significant number of these new cases (up to 70%) is being accounted for by the Key Population (KP). However, stigma and discrimination in our conventional healthcare systems lead to poor access to treatment among these populations. The current study reviews some of the healthcare models implemented for KP HIV program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A retrospective data review of KP patients accessing care using the One Stop Shop (OSS) and Community Clinical Service Assistant Points (CCSAPs) models for HIV care in Zamfara State, Nigeria (May 2022 to May 2023). Important patient data were extracted, analysed and explored in frequency and percentage. Pearson\u2019s chi-square and fisher exact test were also used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 4043 patients, 3737 patients with known viral load were used, CCSAPs had (77.8%) patients and OSS (22.2%). The majority were females (60.7%). The ages were between 25 and 34 years of ages (42.9%). The patients had a mean weight of 58.15Kg. Overal retention to care was (98.6%) with suppression rate of (99.4%), with CCSAPs (99.6%) suppression rate and OSS (99.0%) suppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both the CCSAPs and OSS models demonstrated a high rate of viral load suppression and retention in care for KP.The CCSAPs particularly excelled in viral suppression rates and patient retention. More HIV programs need to adopt these service delivery to improve access to care and sustain the progress for epidemic control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-27087-9","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T02:54:05Z","timestamp":1774234445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breaking barriers: differential service deliveries for community HIV\/AIDS services action and response in Northern Nigeria"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0194-5642","authenticated-orcid":false,"given":"Zayyanu","family":"Shitu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaynab U","family":"Nyako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza Musa","family":"Dahiru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Olusegun","family":"Oyedeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wole","family":"Fajemisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsamad","family":"Salihu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Anyati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"27087_CR1","unstructured":"WHO. WHO recommends long-acting cabotegravir for HIV Prevention. Retrieved August 5th, from 2022. https:\/\/www.who.int\/news\/item\/28-07-2022-who-recommends-long-acting-cabotegravir-for-hiv-prevention."},{"key":"27087_CR2","unstructured":"UNAIDS. Nigeria. Retrieved August, 17th from 2021. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/nigeria."},{"key":"27087_CR3","doi-asserted-by":"publisher","unstructured":"Lo, J., Nwafor, S. U., Schwitters, A. M., Mitchell, A., Sebastian, V., Stafford, K.A., \u2026 McIntyre, A. F. Key population hotspots in Nigeria for targeted HIV program planning: mapping, validation, and reconciliation. JMIR Public Health and Surveillance, 2021;7(2):e25623. https:\/\/doi.org\/10.2196\/25623.","DOI":"10.2196\/25623"},{"issue":"5","key":"27087_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/COH.0000000000000090","volume":"9","author":"G Djomand","year":"2014","unstructured":"Djomand G, Quaye S, Sullivan PS. HIV epidemic among key populations in west Africa. Curr Opin HIV AIDS. 2014;9(5):506. https:\/\/doi.org\/10.1097\/COH.0000000000000090.","journal-title":"Curr Opin HIV AIDS"},{"key":"27087_CR5","doi-asserted-by":"publisher","first-page":"21658","DOI":"10.7448\/IAS.20.5.21658","volume":"20","author":"V Macdonald","year":"2017","unstructured":"Macdonald V, Verster A, Baggaley R. A call for differentiated approaches to delivering HIV services to key populations. J Int AIDS Soc. 2017;20:21658. https:\/\/doi.org\/10.7448\/IAS.20.5.21658.","journal-title":"J Int AIDS Soc"},{"key":"27087_CR6","unstructured":"Nigeria HIV\/AIDS indicator Survey NAIIS. Retrieved, October 17th. from 2018. https:\/\/www.naiis.ng\/."},{"key":"27087_CR7","unstructured":"World Health Organisation. WHO publishes new guidelines on HIV, hepatitis and STIs for key populations. Retrieved October 17th, From 2022. https:\/\/www.who.int\/news\/item\/29-07-2022-who-publishes-new-guidelines-on-hiv--hepatitis-and-sti-for-key-populations."},{"key":"27087_CR8","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd ed. Geneva: World Health Org. 2016. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241549684."},{"key":"27087_CR9","unstructured":"The Global Fund to Fight AIDS, Tuberculosis and Malaria. New toolkit for differentiated care in HIV and TB programs. 2015. Available from: https:\/\/www.theglobalfund.org\/en\/news\/2015\/2015-12-04-new-toolkit-for-differentiated-care-in-hiv-and-tb-programs\/."},{"key":"27087_CR10","unstructured":"Nigerian Investment Promotion Commission. Retrieved from 2023. https:\/\/www.nipc.gov.ng\/nigeria-states\/zamfara-state\/."},{"key":"27087_CR11","unstructured":"UNAIDS. Global HIV\/AIDS Statistics, factsheet. 2023. https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"issue":"7","key":"27087_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S2352-4642(19)30112-9","volume":"3","author":"LG Bekker","year":"2019","unstructured":"Bekker LG. HIV control in young key populations in Africa. Lancet Child Adolesc Health. 2019;3(7):442\u20134.","journal-title":"Lancet Child Adolesc Health"},{"key":"27087_CR13","doi-asserted-by":"crossref","unstructured":"Mumtaz, G. R., Chemaitelly, H., AlMukdad, S., Osman, A., Fahme, S., Rizk, N. A., \u2026Abu-Raddad, L. J. (2022). Status of the HIV epidemic in key populations in the Middle East and north Africa: knowns and unknowns. The Lancet HIV, 9(7), e506-e516,doi.org\/10.1016\/S2352-3018(22)00093-5.","DOI":"10.1016\/S2352-3018(22)00093-5"},{"key":"27087_CR14","doi-asserted-by":"publisher","unstructured":"Shrestha R, Philip S, Shewade HD, Rawal B, Deuba K. Why don\u2019t key populations access HIV testing and counselling centres in Nepal? Findings based on national surveillance survey. BMJ open. 2017;7(12). https:\/\/doi.org\/10.1136\/bmjopen-2017-017408.","DOI":"10.1136\/bmjopen-2017-017408"},{"key":"27087_CR15","doi-asserted-by":"publisher","first-page":"21658","DOI":"10.7448\/IAS.20.5.21658","volume":"20","author":"V Macdonald","year":"2017","unstructured":"Macdonald V, Verster A, Baggaley R. A call for differentiated approaches to delivering HIV services to key populations. J Int AIDS Soc. 2017;20:21658. https:\/\/doi.org\/10.7448\/IAS.20.5.21658.","journal-title":"J Int AIDS Soc"},{"issue":"Supplement 2","key":"27087_CR16","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1097\/QAD.0000000000003082","volume":"35","author":"SM McCluskey","year":"2021","unstructured":"McCluskey SM, Pepperrell T, Hill A, Venter WD, Gupta RK, Siedner MJ. Adherence, resistance, and viral suppression on dolutegravir in sub-Saharan Africa: implications for the TLD era. Aids. 2021;35(Supplement 2):S127\u201335. https:\/\/doi.org\/10.1097\/QAD.0000000000003082.","journal-title":"Aids"},{"key":"27087_CR17","doi-asserted-by":"crossref","unstructured":"Schramm, B., Temfack, E., Descamps, D., Nicholas, S., Peytavin, G., Bitilinyu-Bangoh,J. E., \u2026 Szumilin, E. (2022). Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study. The Lancet HIV, 9(8),. doi.org\/10.1016\/S2352-3018(22)00136-9.","DOI":"10.1016\/S2352-3018(22)00136-9"},{"issue":"2","key":"27087_CR18","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/S2468-2667(18)30265-2","volume":"4","author":"LMA Gangcuangco","year":"2019","unstructured":"Gangcuangco LMA. HIV crisis in the Philippines: urgent actions needed. Lancet Public Health. 2019;4(2):e84. https:\/\/doi.org\/10.1016\/S2468-2667(18)30265-2.","journal-title":"Lancet Public Health"},{"key":"27087_CR19","unstructured":"National Agency for the Control of AIDS (NACA). Nigeria People Living with HIV (PLHIV) Stigma Index 2.0 survey report. Abuja: National Agency for the Control of AIDS; 2021. Available from: https:\/\/naca.gov.ng\/wp-content\/uploads\/2023\/03\/NIGERIA-PLHIV-STIGMA-INDEX-2.0-REPORT_2021.pdf."},{"key":"27087_CR20","unstructured":"Idoko-Asuelimhen O, Alozie A, Iyamu I. Management and monitoring of PLHIV using electronic systems in Nigeria: Lafiya Management Information System (LAMIS). Abuja: Lafiya Management Information System (LAMIS); 2019."},{"issue":"1","key":"27087_CR21","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1186\/s12913-022-08720-w","volume":"22","author":"M Aina","year":"2022","unstructured":"Aina M, Odeyemi K, Ologun O, Ntoimo L, Okonofua F. Patient and health facility attributes associated with skilled birth attendant utilization in Nigeria: A cross-sectional study. BMC Health Serv Res. 2022;22(1):1339.","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"27087_CR22","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1001\/jama.260.12.1743","volume":"260","author":"A Donabedian","year":"1988","unstructured":"Donabedian A. The quality of care: How can it be assessed? JAMA. 1988;260(12):1743\u20138. https:\/\/doi.org\/10.1001\/jama.260.12.1743.","journal-title":"JAMA"},{"key":"27087_CR23","unstructured":"UNAIDS. (n.d.). Key populations [web page]. Retrieved 1st. October, 2025 from https:\/\/www.unaids.org\/en\/topic\/key-populations."},{"issue":"2","key":"27087_CR24","first-page":"79","volume":"3","author":"OL Abodunrin","year":"2010","unstructured":"Abodunrin OL, Bamidele JO, Olugbenga-Bello AI, Parakoyi DB. Preferred choice of health facilities for healthcare among adult residents in Ilorin metropolis, Kwara state, Nigeria. Int J health Res. 2010;3(2):79\u201386.","journal-title":"Int J health Res"},{"issue":"2","key":"27087_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5897\/AJPSIR08.009","volume":"7","author":"AO Melvin","year":"2013","unstructured":"Melvin AO. Prison health in Nigeria: A sociological discourse. Afr J Political Sci Int Relations. 2013;7(2):38\u201341.","journal-title":"Afr J Political Sci Int Relations"},{"key":"27087_CR26","doi-asserted-by":"crossref","unstructured":"Grimsrud, A., Bygrave, H., Doherty, M., Ehrenkranz, P., Ellman, T., Ferris, R., \u2026Bekker, L. G. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression. Journal of the International AIDS Society, 2016;19(1),21484.","DOI":"10.7448\/IAS.19.1.21484"},{"issue":"12","key":"27087_CR27","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(11)70181","volume":"11","author":"T B\u00e4rnighausen","year":"2011","unstructured":"B\u00e4rnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML. Interventions to increase antiretroviral adherence in sub-Saharan Africa: A systematic review of evaluation studies. Lancet Infect Dis. 2011;11(12):942\u201351. https:\/\/doi.org\/10.1016\/S1473-3099(11)70181-.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"27087_CR28","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1097\/QAI.0b013e31829a4aa4","volume":"65","author":"D Govindasamy","year":"2014","unstructured":"Govindasamy D, Meher S, Ebrahim S, Gregson S, Richter L, Darbes L. Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata. J Acquir Immune Defic Syndr. 2014;65(3):e13\u20134. https:\/\/doi.org\/10.1097\/QAI.0b013e31829a4aa4.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"27087_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-2506-4","volume":"15","author":"GI Eluwa","year":"2015","unstructured":"Eluwa GI, Adebajo SB, Eluwa T, Ogbanufe O, Ikpeme B, Ayenigbara O, Ahonsi B, Risher KA. Rising HIV prevalence among men who have sex with men in Nigeria: A trend analysis. BMC Public Health. 2015;15:1\u20138. https:\/\/doi.org\/10.1186\/s12889-015-2506-4.","journal-title":"BMC Public Health"},{"key":"27087_CR30","unstructured":"oint United Nations Programme on HIV\/AIDS. Global HIV & AIDS statistics \u2014 Fact sheet. UNAIDS. Retrieved January 5, 2026, from 2025. https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"27087_CR31","unstructured":"National Agency for the Control of AIDS. National HIV and AIDS strategic framework 2021\u20132025 (Final ed.). Federal Republic of Nigeria. 2021. https:\/\/naca.gov.ng\/wp-content\/uploads\/2022\/03\/National-HIV-and-AIDS-Strategic-Framework-2021-2025-Final.pdf."},{"key":"27087_CR32","doi-asserted-by":"publisher","unstructured":"Levesque J-F, Harris MF, Russell G. Access to health care: Conceptualising access at the interface of health systems and populations. BMC Public Health. 2013;13., Article 1. https:\/\/doi.org\/10.1186\/1471-2458-13-1.","DOI":"10.1186\/1471-2458-13-1"},{"key":"27087_CR33","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2nd ed.). World Health Organization. 2016. https:\/\/apps.who.int\/iris\/handle\/10665\/208825."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27087-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27087-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27087-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:40:16Z","timestamp":1781642416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27087-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27087"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27087-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research ethics committee of the Zamfara State Hospital Services Management Board Research Ethics Committee approved the conduction of this research (HSMB\/MOH\/137\/VOL.1). This study was conducted in accordance with the Declaration of Helsinki and the UNAIDS\/WHO Ethical Guidelines and considerations for HIV research. All consents, confidentialities, and reimbursements were considered for the participants where necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1410"}}